Bisphenol A

Bisphenol A

SCHEMBL6581820

CC(C)(c1ccc(O)cc1)c1ccc(O)cc1.O=C(O)Cl.O=C(O)Cl

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.73
ESR2 Q92731 8/20 0.73
ESRRG P62508 5/20 0.73
CYP3A4 P08684 3/20 0.73
AR P10275 1/20 0.73
HPGD P15428 1/20 0.73
TSHR P16473 1/20 0.73
SLC6A2 P23975 1/20 0.73
SLC6A4 P31645 1/20 0.73
HTR6 P50406 1/20 0.73
SLC6A3 Q01959 1/20 0.73
HSD17B10 Q99714 1/20 0.73
ALDH1A1 P00352 2/20 0.68
TYR P14679 2/20 0.52
LMNA P02545 1/20 0.52
SHBG P04278 1/20 0.43
BLM P54132 1/20 0.41
ESRRB O95718 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bisphenol A SCHEMBL3295660 1.00 ESR1 (0.73) ESR1ESR2ESRRGCYP3A4AR
SCHEMBL10953906 0.94 ESR1 (0.80) ESR1ESR2ESRRGCYP3A4AR
Bisphenol A SCHEMBL1940373 0.91 ESR1 (0.80) ESR1ESR2ESRRGCYP3A4AR
Bisphenol A SCHEMBL23414108 0.91 ESR1 (0.80) ESR1ESR2ESRRGCYP3A4AR
SCHEMBL28822358 0.90 ESR1 (0.80) ESR1ESR2ESRRGCYP3A4AR
Bisphenol A SCHEMBL10555851 0.88 ESR1 (0.76) ESR1ESR2ESRRGCYP3A4AR
Bisphenol A SCHEMBL14631568 0.87 ESRRG (0.67) ESR1ESR2ESRRGCYP3A4AR
Bisphenol A SCHEMBL598259 0.86 ESR1 (0.80) ESR1ESR2ESRRGCYP3A4AR
Bisphenol A SCHEMBL28090475 0.85 ESR1 (0.90) ESR1ESR2ESRRGCYP3A4AR
Bisphenol A SCHEMBL15062 0.85 ESR1 (1.00) ESR1ESR2ESRRGCYP3A4AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4721152-A2 ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS Coreshell Technologies, Inc. (US) 2026-04-08 EP claimed
EP-4635941-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE Nouryon Chemicals International B.V. (NL) 2025-10-22 EP claimed
US-20250302760-A1 BIODEGRADABLE, CONTROLLED RELEASE MICROCAPSULES ENCAPSYS, LLC (US) 2025-10-02 US claimed
EP-4471010-B1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE NOURYON CHEMICALS INT BV (NL) 2025-06-04 EP claimed
US-20240400490-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2024-12-05 US claimed
WO-2024249841-A2 ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS CORESHELL TECHNOLOGIES, INC. (US) 2024-12-05 WO claimed
EP-4471010-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE Nouryon Chemicals International B.V. (NL) 2024-12-04 EP claimed
CN-119059951-A Process for preparing peroxyesters or peroxycarbonates 诺力昂化学品国际有限公司 2024-12-03 CN claimed
EP-4721152-A2 ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS Coreshell Technologies, Inc. (US) 2026-04-08 EP disclosed
EP-4514879-B1 POLYCARBONATE WITH PHENOLIC BUILDING BLOCKS AND LOW CHLORINE CONTENT COVESTRO DEUTSCHLAND AG (DE) 2026-03-04 EP disclosed
EP-4635941-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE Nouryon Chemicals International B.V. (NL) 2025-10-22 EP disclosed
US-20250313665-A1 POLYCARBONATE WITH PHENOLIC BUILDING BLOCKS AND LOW CHLORINE CONTENT COVESTRO DEUTSCHLAND AG (DE) 2025-10-09 US disclosed
US-20250302759-A1 BIODEGRADABLE, CONTROLLED RELEASE MICROCAPSULES ENCAPSYS, LLC (US) 2025-10-02 US disclosed
US-20250302760-A1 BIODEGRADABLE, CONTROLLED RELEASE MICROCAPSULES ENCAPSYS, LLC (US) 2025-10-02 US disclosed
EP-3999126-A1 COAXIAL FIBERS CONTAINING LIQUID Symrise AG (DE) 2022-05-25 EP disclosed
WO-2022047268-A1 DEPOSITION OF FILMS ONTO BATTERY MATERIAL POWDERS CORESHELL TECHNOLOGIES, INC. (US) 2022-03-03 WO disclosed
EP-1060175-B1 TRYPTASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2004-11-17 EP disclosed
EP-1060171-A2 TRYPTASE INHIBITORS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2000-12-20 EP disclosed
WO-1999040073-A2 TRYPTASE INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1999-08-12 WO disclosed
US-5480753-A DURABILITY RICOH COMPANY, LTD. (JP) 1996-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400490-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE GPX4, PRDX4, PRDX2 ESR1 3580/4885ESR2 4238/4885ESRRG 4320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.